Concepts (178)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, GABA | 7 | 2025 | 28 | 3.190 |
Why?
|
| Manganese | 5 | 2022 | 89 | 1.790 |
Why?
|
| Brain | 13 | 2025 | 1452 | 1.720 |
Why?
|
| Lead | 5 | 2020 | 101 | 1.560 |
Why?
|
| Dystonia | 2 | 2022 | 10 | 1.490 |
Why?
|
| Cation Transport Proteins | 2 | 2022 | 34 | 1.470 |
Why?
|
| Microglia | 5 | 2025 | 204 | 1.460 |
Why?
|
| Behavior, Animal | 2 | 2021 | 369 | 0.920 |
Why?
|
| Uterine Rupture | 1 | 2023 | 5 | 0.830 |
Why?
|
| Parkinson Disease, Secondary | 2 | 2021 | 11 | 0.810 |
Why?
|
| Manganese Poisoning | 2 | 2021 | 16 | 0.800 |
Why?
|
| Brain Chemistry | 2 | 2020 | 140 | 0.790 |
Why?
|
| Parkinsonian Disorders | 1 | 2022 | 42 | 0.760 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2022 | 20 | 0.750 |
Why?
|
| Premature Birth | 1 | 2023 | 94 | 0.730 |
Why?
|
| Pregnancy Complications | 1 | 2023 | 134 | 0.730 |
Why?
|
| Bronchitis, Chronic | 1 | 2021 | 16 | 0.720 |
Why?
|
| Pre-Eclampsia | 1 | 2022 | 68 | 0.700 |
Why?
|
| Dopamine | 3 | 2021 | 272 | 0.700 |
Why?
|
| Lead Poisoning, Nervous System | 1 | 2020 | 5 | 0.690 |
Why?
|
| Receptors, Opioid, mu | 1 | 2020 | 50 | 0.670 |
Why?
|
| Neurodegenerative Diseases | 1 | 2021 | 138 | 0.650 |
Why?
|
| Myocardial Infarction | 1 | 2021 | 242 | 0.600 |
Why?
|
| Frontal Lobe | 1 | 2019 | 58 | 0.600 |
Why?
|
| Animals | 17 | 2025 | 16695 | 0.590 |
Why?
|
| Central Nervous System Diseases | 1 | 2018 | 32 | 0.570 |
Why?
|
| Positron-Emission Tomography | 7 | 2021 | 93 | 0.560 |
Why?
|
| Alzheimer Disease | 1 | 2025 | 972 | 0.550 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2017 | 90 | 0.520 |
Why?
|
| Synaptic Vesicles | 1 | 2016 | 31 | 0.510 |
Why?
|
| Cardiovascular Diseases | 1 | 2023 | 729 | 0.510 |
Why?
|
| Presynaptic Terminals | 1 | 2016 | 54 | 0.500 |
Why?
|
| Synapses | 1 | 2016 | 184 | 0.460 |
Why?
|
| Receptors, GABA-A | 3 | 2018 | 65 | 0.430 |
Why?
|
| Nerve Tissue Proteins | 2 | 2013 | 382 | 0.420 |
Why?
|
| Mice | 7 | 2025 | 6490 | 0.410 |
Why?
|
| Hippocampus | 1 | 2016 | 591 | 0.400 |
Why?
|
| Lead Poisoning | 1 | 2013 | 25 | 0.400 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2013 | 133 | 0.380 |
Why?
|
| Schizophrenia | 1 | 2013 | 91 | 0.380 |
Why?
|
| Substantia Nigra | 2 | 2022 | 49 | 0.360 |
Why?
|
| Mice, Inbred C57BL | 4 | 2021 | 1804 | 0.360 |
Why?
|
| Female | 11 | 2025 | 24018 | 0.350 |
Why?
|
| Mice, Transgenic | 2 | 2025 | 658 | 0.340 |
Why?
|
| Humans | 17 | 2025 | 42163 | 0.330 |
Why?
|
| Mice, Knockout | 3 | 2022 | 1010 | 0.320 |
Why?
|
| Infant, Newborn | 2 | 2023 | 960 | 0.320 |
Why?
|
| Rats, Long-Evans | 2 | 2020 | 108 | 0.290 |
Why?
|
| Male | 11 | 2025 | 22779 | 0.270 |
Why?
|
| Pregnancy | 2 | 2023 | 1737 | 0.260 |
Why?
|
| Disease Models, Animal | 4 | 2025 | 1554 | 0.260 |
Why?
|
| Up-Regulation | 2 | 2025 | 534 | 0.220 |
Why?
|
| Hysterectomy | 1 | 2023 | 39 | 0.200 |
Why?
|
| Rats | 4 | 2020 | 3701 | 0.200 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 1 | 2003 | 57 | 0.190 |
Why?
|
| Simian immunodeficiency virus | 1 | 2003 | 61 | 0.190 |
Why?
|
| Neuroglia | 2 | 2018 | 131 | 0.190 |
Why?
|
| Cadmium | 1 | 2021 | 54 | 0.180 |
Why?
|
| Gestational Age | 1 | 2022 | 195 | 0.180 |
Why?
|
| Neostriatum | 1 | 2021 | 28 | 0.180 |
Why?
|
| Pyrimidines | 5 | 2017 | 130 | 0.180 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2021 | 88 | 0.170 |
Why?
|
| Voltage-Dependent Anion Channels | 1 | 2020 | 5 | 0.170 |
Why?
|
| Intracellular Membranes | 1 | 2020 | 37 | 0.170 |
Why?
|
| Acetamides | 4 | 2017 | 12 | 0.170 |
Why?
|
| Nutrition Surveys | 1 | 2021 | 263 | 0.170 |
Why?
|
| Psychomotor Performance | 1 | 2021 | 156 | 0.160 |
Why?
|
| Cytosol | 1 | 2020 | 98 | 0.160 |
Why?
|
| Heme | 1 | 2020 | 72 | 0.160 |
Why?
|
| Pyrazoles | 4 | 2017 | 93 | 0.160 |
Why?
|
| Porphyrins | 1 | 2020 | 57 | 0.160 |
Why?
|
| Endoplasmic Reticulum | 1 | 2020 | 108 | 0.160 |
Why?
|
| Macaca fascicularis | 1 | 2019 | 64 | 0.150 |
Why?
|
| AIDS Dementia Complex | 2 | 2014 | 116 | 0.150 |
Why?
|
| Receptors, Dopamine | 1 | 2019 | 30 | 0.150 |
Why?
|
| Neurotoxicity Syndromes | 2 | 2016 | 37 | 0.150 |
Why?
|
| Pilot Projects | 3 | 2017 | 733 | 0.150 |
Why?
|
| Adult | 5 | 2023 | 13458 | 0.150 |
Why?
|
| Memory, Short-Term | 1 | 2019 | 56 | 0.150 |
Why?
|
| Motor Activity | 1 | 2021 | 438 | 0.150 |
Why?
|
| Endothelial Cells | 1 | 2021 | 324 | 0.150 |
Why?
|
| Football | 2 | 2017 | 11 | 0.140 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2017 | 577 | 0.140 |
Why?
|
| Inflammation | 2 | 2016 | 729 | 0.140 |
Why?
|
| Athletes | 2 | 2017 | 61 | 0.140 |
Why?
|
| Reactive Oxygen Species | 1 | 2020 | 518 | 0.130 |
Why?
|
| Attention | 1 | 2019 | 165 | 0.130 |
Why?
|
| Prospective Studies | 1 | 2021 | 1574 | 0.130 |
Why?
|
| Aging | 1 | 2022 | 764 | 0.130 |
Why?
|
| Prevalence | 1 | 2021 | 1597 | 0.130 |
Why?
|
| Models, Biological | 1 | 2020 | 711 | 0.130 |
Why?
|
| Vehicle Emissions | 1 | 2016 | 22 | 0.130 |
Why?
|
| Protein Binding | 1 | 2020 | 1076 | 0.130 |
Why?
|
| Hazardous Substances | 1 | 2016 | 18 | 0.130 |
Why?
|
| Animals, Newborn | 1 | 2017 | 350 | 0.130 |
Why?
|
| Retrospective Studies | 1 | 2023 | 2485 | 0.130 |
Why?
|
| Drug Administration Schedule | 1 | 2016 | 153 | 0.130 |
Why?
|
| Mitochondria | 1 | 2020 | 516 | 0.130 |
Why?
|
| Risk Factors | 2 | 2023 | 3942 | 0.130 |
Why?
|
| Random Allocation | 1 | 2016 | 145 | 0.130 |
Why?
|
| Brain Concussion | 1 | 2017 | 35 | 0.120 |
Why?
|
| Young Adult | 3 | 2023 | 4936 | 0.120 |
Why?
|
| Toxicology | 1 | 2015 | 8 | 0.120 |
Why?
|
| Nervous System | 1 | 2015 | 33 | 0.120 |
Why?
|
| Cross-Sectional Studies | 2 | 2021 | 3077 | 0.120 |
Why?
|
| Air Pollutants | 1 | 2016 | 127 | 0.120 |
Why?
|
| Neuropsychological Tests | 4 | 2017 | 281 | 0.110 |
Why?
|
| Mental Disorders | 1 | 2018 | 377 | 0.110 |
Why?
|
| Portacaval Shunt, Surgical | 1 | 2013 | 1 | 0.110 |
Why?
|
| Hepatic Encephalopathy | 1 | 2013 | 9 | 0.110 |
Why?
|
| Radiopharmaceuticals | 2 | 2014 | 62 | 0.100 |
Why?
|
| Reflex, Abnormal | 1 | 2013 | 4 | 0.100 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2013 | 105 | 0.100 |
Why?
|
| Cerebral Ventricles | 1 | 2013 | 23 | 0.100 |
Why?
|
| Mice, Mutant Strains | 1 | 2013 | 85 | 0.100 |
Why?
|
| Age Factors | 1 | 2016 | 1139 | 0.100 |
Why?
|
| Air Pollutants, Occupational | 1 | 2011 | 10 | 0.090 |
Why?
|
| Carrier Proteins | 1 | 2013 | 318 | 0.090 |
Why?
|
| Occupational Diseases | 1 | 2011 | 53 | 0.090 |
Why?
|
| Isoquinolines | 3 | 2013 | 50 | 0.090 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 1066 | 0.090 |
Why?
|
| Occupational Exposure | 1 | 2011 | 89 | 0.090 |
Why?
|
| Biomedical Research | 1 | 2016 | 467 | 0.090 |
Why?
|
| Oxidative Stress | 1 | 2016 | 990 | 0.080 |
Why?
|
| Molecular Probes | 1 | 2009 | 23 | 0.080 |
Why?
|
| Sex Factors | 1 | 2013 | 1008 | 0.080 |
Why?
|
| Carbon Radioisotopes | 3 | 2017 | 14 | 0.080 |
Why?
|
| Neoplasms | 1 | 2016 | 1341 | 0.060 |
Why?
|
| Macaca nemestrina | 1 | 2003 | 1 | 0.050 |
Why?
|
| Encephalitis, Viral | 1 | 2003 | 6 | 0.050 |
Why?
|
| Gliosis | 1 | 2003 | 25 | 0.050 |
Why?
|
| Risk Assessment | 2 | 2015 | 845 | 0.040 |
Why?
|
| Phenotype | 2 | 2014 | 774 | 0.040 |
Why?
|
| Macrophages | 1 | 2003 | 515 | 0.040 |
Why?
|
| Antineoplastic Agents | 2 | 2005 | 979 | 0.040 |
Why?
|
| Retirement | 1 | 2017 | 12 | 0.030 |
Why?
|
| Glutamate-Cysteine Ligase | 1 | 2016 | 17 | 0.030 |
Why?
|
| Aryldialkylphosphatase | 1 | 2016 | 14 | 0.030 |
Why?
|
| Government Agencies | 1 | 2016 | 9 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2016 | 74 | 0.030 |
Why?
|
| Osteopontin | 1 | 2016 | 45 | 0.030 |
Why?
|
| Particulate Matter | 1 | 2016 | 80 | 0.030 |
Why?
|
| Particle Size | 1 | 2016 | 267 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2017 | 170 | 0.030 |
Why?
|
| United States | 2 | 2017 | 5072 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2016 | 310 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2015 | 146 | 0.030 |
Why?
|
| Atrophy | 1 | 2014 | 51 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 2016 | 253 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 438 | 0.030 |
Why?
|
| Organ Size | 1 | 2014 | 167 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2016 | 421 | 0.030 |
Why?
|
| Carbon Isotopes | 1 | 2014 | 33 | 0.030 |
Why?
|
| Genetic Variation | 1 | 2016 | 429 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2013 | 141 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2017 | 1266 | 0.030 |
Why?
|
| Imidazoles | 1 | 2013 | 138 | 0.020 |
Why?
|
| Prognosis | 1 | 2015 | 850 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2013 | 282 | 0.020 |
Why?
|
| Anti-Retroviral Agents | 1 | 2014 | 158 | 0.020 |
Why?
|
| Cytokines | 1 | 2016 | 661 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 683 | 0.020 |
Why?
|
| Middle Aged | 3 | 2014 | 11819 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2013 | 159 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2017 | 1729 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 1058 | 0.020 |
Why?
|
| Occupational Health | 1 | 2011 | 30 | 0.020 |
Why?
|
| Public Health | 1 | 2016 | 405 | 0.020 |
Why?
|
| Aspartic Acid | 1 | 2011 | 51 | 0.020 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2011 | 81 | 0.020 |
Why?
|
| Models, Animal | 1 | 2011 | 149 | 0.020 |
Why?
|
| Genotype | 1 | 2014 | 796 | 0.020 |
Why?
|
| Tomography, Emission-Computed | 1 | 2009 | 13 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2009 | 116 | 0.020 |
Why?
|
| Pneumonia | 1 | 2009 | 60 | 0.020 |
Why?
|
| Child | 1 | 2016 | 3381 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2016 | 2111 | 0.020 |
Why?
|
| Aged | 1 | 2014 | 7982 | 0.010 |
Why?
|